University of Virginia Cancer Center researchers have explained the failure of immune checkpoint therapy for ovarian cancer by discovering how gut bacteria interfere with the treatment.
Scientists have developed new light-sensitive chemicals that can radically improve the treatment of aggressive cancers with minimal side effects.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback